Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years
Portfolio Pulse from Benzinga Insights
Krystal Biotech (NASDAQ:KRYS) has significantly outperformed the market over the past 5 years, delivering an average annual return of 32.25%. A $100 investment in KRYS 5 years ago would now be worth $446.11, with the stock currently priced at $179.65 and a market cap of $5.13 billion.
June 25, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Krystal Biotech has delivered impressive returns over the past 5 years, significantly outperforming the market with an average annual return of 32.25%. The stock is currently priced at $179.65 with a market cap of $5.13 billion.
The article highlights the strong historical performance of Krystal Biotech, which is likely to positively influence investor sentiment and potentially drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100